TARS Tarsus Pharmaceuticals, Inc.

HealthcareBiotechnology

$63.96

▼ 1.24%

41

QScore Signal

Hold

Confidence: MEDIUM

Long-Term

35

Short-Term

46

Value

24

P/E-56.93

8

P/B7.87

43

P/S5.09

46

EV/EBITDA-66.24

5

Growth

68

Revenue Growth146.7%

100

EPS Growth48.2%

46

FCF Growth73.6%

52

Momentum

61

12-Month Return37.7%

75

3-Month Return3.2%

65

1-Month Return-11.0%

33

RSI (14)39.28

50

50/200 MABullish

75

Profitability

25

ROE-14.2%

49

ROA-8.3%

0

Gross Margin90.4%

72

Operating Margin-9.5%

7

Net Margin-9.0%

12

FCF Yield-1.2%

5

Risk

25

Beta0.53

55

60-Day Volatility42.7%

1

Generated 5/7/2026, 10:44:31 PM · How is this calculated?

QScore Analysis